Zimmerman Daniel H

Avg. Two Year Performance

(9%) Avg. Purchase Return
(5%) Compound
(8%) Avg. Sale Return
(4%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(3%)6%(4%)(9%)
Purchase Success Rate2 of 52 of 51 of 51 of 51 of 5
Average Sale Return(5%)8%2%45%(8%)
Sale Success Rate1 of 32 of 31 of 32 of 31 of 3

CEL-SCI Corp.

Drugs » Biotechnology

Senior Vice President:

Holdings: 120.23K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--